Editor’s Note: This interview was conducted at #BIO2018. Please pardon the background noise.
Barry Greene, President of Alnylam, joined the company in 2003 and has more than 25 years of experience in healthcare, pharmaceutical, and biotechnology industries. In this video, Barry provides an overview of his company and the science of RNA interference (RNAi), which represents a completely new approach to drug discovery and development. The 2006 Nobel Prize for Physiology or Medicine, awarded to Craig Mello and Andrew Fire, recognized the importance of RNAi as a major scientific discovery.
